Danaher Corporation has entered into an agreement to acquire privately-held Aldevron for approximately $9.6 billion.   Founded in 1998 by Michael Chambers and John Ballantyne, Aldevron is headquartered in Fargo, ND and employs approximately 600 people. Aldevron manufactures high-quality plasmid DNA, mRNA, and proteins, serving biotechnology and pharmaceutical customers across research, clinical and commercial applications. Aldevron will operate as a standalone operating company and brand within ...